Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sirolimus in Treating Patients With Angiomyolipoma of the Kidney

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00126672
First received: August 2, 2005
Last updated: February 1, 2010
Last verified: October 2008